alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › similar

similar

3 studies tagged similar, dated 2011-07-01 to 2024-01-30. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Similar brain proteomic signatures in Alzheimer's disease and epilepsy 2024-01-30
  2. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients 2013-06-28
  3. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease 2011-07-01

Studies

3 studies carry this tag.

Date range

2011 to 2024

Top journals

  • Acta neuropathologica 1
  • Brain : a journal of neurology 1
  • Brain pathology (Zurich, Switzerland) 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Similar brain proteomic signatures in Alzheimer's disease and epilepsy

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Acta neuropathologica 2024-01-30 Biomarkers

    The prevalence of epilepsy is increased among Alzheimer's Disease (AD) patients and cognitive impairment is common among people with epilepsy.

  2. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Brain pathology (Zurich, Switzerland) 2013-06-28 Brain scans and imaging

    Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative disorders, and are characterized by deposition of specific proteins in the brain.

  3. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Brain : a journal of neurology 2011-07-01 Brain scans and imaging

    While the clinical presentation of posterior cortical atrophy is clearly distinct from typical Alzheimer's disease, neuropathological studies have suggested that most patients with posterior cortical atrophy have Alzheimer's disease with an atypical visual presentation.

All topic tags with their study counts